“A Phase 2 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Vaccine Based on Adeno-Associated Virus”, AIDS Res Hum Retroviruses, vol. 26, pp. 933-942, 2010.,
“CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa”, PLoS ONE, vol. 4, no. 2, p. e4401, 2009.,
“Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials”, PLoS ONE, vol. 3, p. e2043, 2008.,
“A Cross-Sectional Study in Eastern and Southern Africa to Characterize Laboratory Reference Intervals in Healthy Adults for HIV Prevention Trials”, in AIDS Vaccine 2008 Conference, Cape Town, South Africa, 2008.
“A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant Modified Vaccinia Ankara (rMVA) Virus Preventive Multigenic HIV Subtype C Vaccine (TBC-M4) in Indian Volunteers”, in Keystone Symposia Global Health Series: Pathogenesis and Control of Emerging Infections and Drug Resistant Organisms, Bangkok, Thailand, 2008.,